Abiopharma

🔍 Flammer Martina M.D. (Executive)

Company: INSMED Inc (INSM)

Report Date: 2026-01-06

Detailed Transactions and Holdings:

• Acquired 8,570 shares of Common Stock at $26.43 per share (Direct)
  Date: 2026-01-06 | Code: M | equity_swap_involved: 0 | shares_owned_after: 103,324.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 4,783 shares of Common Stock at $173.47 per share (Direct)
  Date: 2026-01-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 98,541.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 2,830 shares of Common Stock at $174.21 per share (Direct)
  Date: 2026-01-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 95,711.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 957 shares of Common Stock at $175.01 per share (Direct)
  Date: 2026-01-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 94,754.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 1,615 shares of Common Stock at $173.33 per share (Direct)
  Date: 2026-01-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 93,139.00 | transaction_form_type: 4 | Footnotes: F5
• Sold 1,434 shares of Common Stock at $175.84 per share (Direct)
  Date: 2026-01-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 91,705.00 | transaction_form_type: 4 | Footnotes: F5, F6
• Sold 1,660 shares of Common Stock at $173.87 per share (Direct)
  Date: 2026-01-08 | Code: S | equity_swap_involved: 0 | shares_owned_after: 90,045.00 | transaction_form_type: 4 | Footnotes: F5, F7
• Sold 3,251 shares of Common Stock at $174.17 per share (Direct)
  Date: 2026-01-08 | Code: S | equity_swap_involved: 0 | shares_owned_after: 86,794.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 8,570 shares of Stock Option (right to buy) at $26.43 per share (Derivative)
  Date: 2026-01-06 | Code: M | Expires: 2032-01-06 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F8

Footnotes:

• F1: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
• F2: This is the weighted average sales price representing 4,783 shares sold at prices ranging from $172.89 to $173.87 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
• F3: This is the weighted average sales price representing 2,830 shares sold at prices ranging from $173.92 to $174.80 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
• F4: This is the weighted average sales price representing 957 shares sold at prices ranging from $174.97 to $175.12 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
• F5: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees.
• F6: This is the weighted average sales price representing 1,434 shares sold at prices ranging from $175.72 to $176.00 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
• F7: This is the weighted average sales price representing 1,660 shares sold at prices ranging from $173.87 to $173.90 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
• F8: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.